Molecular biologist and Washington University School of Medicine in St. Louis professor Shin-ichiro Imai, PhD, discusses his latest research with NMN (nicotinamide mononucleotide) as a potential treatment for diabetes. NMN shows a significant improvement of diabetes symptoms in early tests and could be ready for human testing soon.
Link to this comment:
All Comments (0)